Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India
Clinical Trial
[키워드] acute respiratory distress
Anti-inflammatory
Anti-inflammatory therapy
appear
clinical recovery
COVID-19
COVID-19 pneumonia
COVID-19 therapy
cytokine release
death in COVID-19
Demand
died
distress
dose
enrolled
fraction
Hospital admission
hospital discharge
immunomodulatory effect
immunomodulatory therapy
India
inflammatory cascade
initial
interfere
Interim result
Low dose radiotherapy
lung
management guideline
material
median time
Oxygenation
Patient
patients
patients with moderate
phase 2 trial
Pneumonia
radiation therapy
reducing
respiratory frequency
RT-PCR
selected
Severe COVID-19 pneumonia
severity
SpO2
SpO2/FiO2
statistically significant
statistically significant reduction
supplemental oxygen
symptom onset
syndrome
translate
treated
Treatment
Viral pneumonia
[DOI] 10.1016/j.radonc.2021.08.001 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1016/j.radonc.2021.08.001 PMC 바로가기 [Article Type] Clinical Trial